What we build
Life sciences market intelligence, built for your market
Continuously enriched life sciences intelligence, built for your market: companies, people, clinical activity, funding and news, linked to your accounts.
The market, as it is today
Comprehensive, continuously enriched life sciences intelligence, purpose-built for the market it describes and landed in your own database.
Classified the way the market divides
Mapped by modality, clinical phase, therapeutic area and funding, so an account's fit is a fact, not a guess.
The right people inside each account
People found, filtered, verified and given a persona inside each account.
Trials tied to who runs them
Clinical trials linked to the companies, institutions and investigators behind them.
Who has the money for the problem
Grants, rounds and filings linked to the accounts they change, so you see which companies can act now.
The science behind the company
Publications, patents and drug candidates, tied to the companies and labs doing the work.
What changed this week
News and conferences landed against your accounts, with the academic market of institutions, investigators and labs alongside the companies.
How the intelligence reaches the work
Intelligence is worth what it changes.
Landed
Every source lands in one database built for the market it describes, so a question asked of it has one answer.
Matched
A trial, a grant, a filing, a patent, a paper or a news article is matched to the company it concerns.
Read through your context
Your context says what the data means for you, and writes its tags and checks back into the records: which segment, which fit, which persona.
Scored
The market is mapped and scored, read against your segments and your offer.
Acted on
Each message is built on the account intelligence and the contact's signal, grounded in what the source says. A person decides the move.
Seeded on the first day, sharper every week after
Your database is seeded from our own life-sciences data, filtered to your market, so your team works from the start. From there agents enrich it continuously, and the feeds refresh on their own.
Signals can come from anywhere the market lives, correlated in one place. Where a source doesn't say something, the field stays empty. Nothing is invented.
It's yours: your own database, with full export any time. The data, the context and the configuration carry forward, whoever runs the system.
Market intelligence, in plain answers
What is life sciences market intelligence?
A continuously enriched view of the companies, people, clinical activity, funding and news that define a life sciences market, linked to your accounts and kept current.
Is this a study we buy once?
No. This is a living database inside your own system, enriched continuously and wired into targeting, messaging and the pipeline.
What sources does it draw on?
Trials, grants, filings, patents, papers, the FDA, the drug pipeline and the news, plus the sources your team already uses, each matched to your accounts.
Can investors and analysts use it?
Yes. Financial teams evaluating the life sciences market use the same intelligence, and we work with them on how to read it, alongside the commercial teams it was built for.
Next step
Bring us your market. We'll show you the system.
Every engagement starts the same way: one working session on your market, your buyers and your goals, before anyone proposes anything.